Q-Med AB: Invitation to conference call regarding interim report January-September, 2009

Time: Friday, October 23, 2009 at 10.30 a.m. CET. To join the conference: Swedish dial in number: +46 8 5052 0114 UK dial in number: +44 207 1620 177 Q-Med participants: Bengt Ågerup, CEO Alexander Kotsinas, CFO Karin Falck, Director Corporate Communications Q-Med AB’s Q3 report will be released 08.00 on October 23, 2009. The slide presentation will be available at www.q-med.com, and Investors/Presentations. A recorded version of the presentation will be available for seven working days on tel: Sweden +46 8 505 203 33 or UK +44 20 7031 4064, access code: 84 83 70. Financial information from Q-Med during 2010 12 February Year-end Report 2009 23 April Interim Report January - March 2010 28 April Annual General Meeting 22 July Interim Report January – June 2010 22 October Interim Report January – September 2010

About Us

Q-Med is a rapidly growing and profitable biotechnology and medical device company that develops, produces and markets medical implants. Operations focus on four areas, Esthetics, Orthopedics, Uro-Gynecology, and Cell Therapy and Encapsulation.

Subscribe

Documents & Links